BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 28042874)

  • 1. In vitro assessment of the glucose-lowering effects of berberrubine-9-O-β-D-glucuronide, an active metabolite of berberrubine.
    Yang N; Sun RB; Chen XL; Zhen L; Ge C; Zhao YQ; He J; Geng JL; Guo JH; Yu XY; Fei F; Feng SQ; Zhu XX; Wang HB; Fu FH; Aa JY; Wang GJ
    Acta Pharmacol Sin; 2017 Mar; 38(3):351-361. PubMed ID: 28042874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High fat diet aggravates the nephrotoxicity of berberrubine by influencing on its pharmacokinetic profile.
    Yang N; Sun R; Zhao Y; He J; Zhen L; Guo J; Geng J; Xie Y; Wang J; Feng S; Fei F; Liao X; Zhu X; Wang H; Fu F; Aa J; Wang G
    Environ Toxicol Pharmacol; 2016 Sep; 46():319-327. PubMed ID: 27525563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory Effects of Endogenous Linoleic Acid and Glutaric Acid on the Renal Glucuronidation of Berberrubine in Mice and on Recombinant Human UGT1A7, 1A8, and 1A9.
    Yang N; Li S; Yan C; Sun R; He J; Xie Y; Peng Y; Wang G; Aa J
    Mol Pharmacol; 2018 Mar; 93(3):216-227. PubMed ID: 29351921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Berberine analogue IMB-Y53 improves glucose-lowering efficacy by averting cellular efflux especially P-glycoprotein efflux.
    Shan YQ; Ren G; Wang YX; Pang J; Zhao ZY; Yao J; You XF; Si SY; Song DQ; Kong WJ; Jiang JD
    Metabolism; 2013 Mar; 62(3):446-56. PubMed ID: 23079743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A rapid method for simultaneous quantification of berberine, berbamine, magnoflorine and berberrubine in mouse serum using UPLC-MS/MS.
    Liang X; Xiang Y; Li Y; Feng P; Qin Y; Lai X
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Apr; 1142():122040. PubMed ID: 32145638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Hypoglycemic Effect of Berberine and Berberrubine Involves Modulation of Intestinal Farnesoid X Receptor Signaling Pathway and Inhibition of Hepatic Gluconeogenesis.
    Sun R; Kong B; Yang N; Cao B; Feng D; Yu X; Ge C; Feng S; Fei F; Huang J; Lu Z; Xie Y; Yang CS; Guo GL; Wang G; Aa J
    Drug Metab Dispos; 2021 Mar; 49(3):276-286. PubMed ID: 33376148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Berberrubine, a Main Metabolite of Berberine, Alleviates Non-Alcoholic Fatty Liver Disease
    Yang S; Cao S; Li C; Zhang J; Liu C; Qiu F; Kang N
    Front Pharmacol; 2022; 13():913378. PubMed ID: 35873595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic Activation and Covalent Protein Binding of Berberrubine: Insight into the Underlying Mechanism Related to Its Hepatotoxicity.
    Wang K; Rao J; Zhang T; Gao Q; Zhang J; Guang C; Ding L; Qiu F
    Drug Des Devel Ther; 2020; 14():4423-4438. PubMed ID: 33122887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative pharmacokinetics and safety assessment of transdermal berberine and dihydroberberine.
    Buchanan B; Meng Q; Poulin MM; Zuccolo J; Azike CG; Gabriele J; Baranowski DC
    PLoS One; 2018; 13(3):e0194979. PubMed ID: 29579096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue distribution of berberine and its metabolites after oral administration in rats.
    Tan XS; Ma JY; Feng R; Ma C; Chen WJ; Sun YP; Fu J; Huang M; He CY; Shou JW; He WY; Wang Y; Jiang JD
    PLoS One; 2013; 8(10):e77969. PubMed ID: 24205048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression.
    Zhang H; Wei J; Xue R; Wu JD; Zhao W; Wang ZZ; Wang SK; Zhou ZX; Song DQ; Wang YM; Pan HN; Kong WJ; Jiang JD
    Metabolism; 2010 Feb; 59(2):285-92. PubMed ID: 19800084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined analytical approaches to define biodistribution and biological activity of semi-synthetic berberrubine, the active metabolite of natural berberine.
    Porru E; Franco P; Calabria D; Spinozzi S; Roberti M; Caliceti C; Roda A
    Anal Bioanal Chem; 2018 Jun; 410(15):3533-3545. PubMed ID: 29411090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of berberrubine metabolites in rats by using ultra-high performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry.
    Wang K; Qiao M; Chai L; Cao S; Feng X; Ding L; Qiu F
    Fitoterapia; 2018 Jan; 124():23-33. PubMed ID: 28993283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, and cholesterol-lowering efficacy for prodrugs of berberrubine.
    Li YH; Li Y; Yang P; Kong WJ; You XF; Ren G; Deng HB; Wang YM; Wang YX; Jiang JD; Song DQ
    Bioorg Med Chem; 2010 Sep; 18(17):6422-8. PubMed ID: 20673726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Excretion of berberine and its metabolites in oral administration in rats.
    Ma JY; Feng R; Tan XS; Ma C; Shou JW; Fu J; Huang M; He CY; Chen SN; Zhao ZX; He WY; Wang Y; Jiang JD
    J Pharm Sci; 2013 Nov; 102(11):4181-92. PubMed ID: 24006193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoglycemic and insulin-sensitizing effects of berberine in high-fat diet- and streptozotocin-induced diabetic rats.
    Wang Y; Campbell T; Perry B; Beaurepaire C; Qin L
    Metabolism; 2011 Feb; 60(2):298-305. PubMed ID: 20304443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic interactions between metformin and berberine in rats: Role of oral administration sequences and microbiota.
    Lyu Y; Zhang Y; Yang M; Lin L; Yang X; Cheung SCK; Shaw PC; Chan PKS; Kong APS; Zuo Z
    Life Sci; 2019 Oct; 235():116818. PubMed ID: 31473193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 8,8-Dimethyldihydroberberine with improved bioavailability and oral efficacy on obese and diabetic mouse models.
    Cheng Z; Chen AF; Wu F; Sheng L; Zhang HK; Gu M; Li YY; Zhang LN; Hu LH; Li JY; Li J
    Bioorg Med Chem; 2010 Aug; 18(16):5915-24. PubMed ID: 20663675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Berberine metabolites could induce low density lipoprotein receptor up-regulation to exert lipid-lowering effects in human hepatoma cells.
    Zhou Y; Cao S; Wang Y; Xu P; Yan J; Bin W; Qiu F; Kang N
    Fitoterapia; 2014 Jan; 92():230-7. PubMed ID: 24321576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Berberine, a plant alkaloid with lipid- and glucose-lowering properties: From in vitro evidence to clinical studies.
    Pirillo A; Catapano AL
    Atherosclerosis; 2015 Dec; 243(2):449-61. PubMed ID: 26520899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.